What about Wuhu Sino-Canadian Biopharmaceutical Co., Ltd.?

Wuhu Sino-Canadian Biopharmaceutical Co., Ltd. was established in April 2008, located in the high-tech industrial development zone of Yijiang District, Anhui Province. Is a modern pharmaceutical enterprise specializing in drug production, research and development and sales. 2011/The company's first-phase tablet and hard capsule workshop passed the national GMP certification at one time, and the second-phase workshop has also started construction. While producing existing products, the company attaches great importance to the research and development of new drugs, among which the clinical trial of the national third-class new drug "glucosamine chondroitin sulfate tablets" has ended and is being declared for production; The national first-class new drug "ω-3 polyunsaturated fatty acid capsules" is about to enter the third phase of clinical trials, and the research and development of these new drugs has provided strong support for the company's subsequent development. The company has more than 0/00 employees/kloc, 90% of whom have bachelor degree or above. The company has always attached great importance to the introduction and cultivation of talents, adhered to the "people-oriented" management concept, gave full play to the ability and enthusiasm of every employee, adhered to the motto of "high efficiency, innovation and Excellence", and under the influence of the corporate culture of "caring and responsibility", devoted itself to serving people's health and providing the society with high-quality drugs with clear curative effect and fair price.

Legal Representative: Hu Hui.

Established: June 2008-1 1

Registered capital: 30 million yuan.

Industrial and commercial registration number: 34020000028745

Type of enterprise: joint stock limited company (unlisted, invested or controlled by natural persons)

Company Address: High-tech Industrial Development Zone, Wuhu City, Anhui Province